Investigación

Dianas farmacológicas en inflamación y enfermedades metabólicas

Buscador de publicaciones

Publicaciones

  • Zarei M, Pujol E, Quesada T, Villarroya-Gombau F, Barroso E, Vázquez S, Pizarro J, Palomer FX and Vazquez M.

    Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21.

    BRITISH JOURNAL OF PHARMACOLOGY . 176(13): 2292-2305. Nº de citas: 13

    [doi:10.1111/bph.14678]

  • Zarei M, Barroso E, Palomer FX, Escolà-Gil JC, Cedó L, Wahli W and Vazquez M.

    Pharmacological PPARß/d activation upregulates VLDLR in hepatocytes.

    Clinica e Investigacion en Arteriosclerosis . 31(3): 111-118. Nº de citas: 9

    [doi:10.1016/j.arteri.2019.01.004]

  • Busquets O, Eritja À, López BM, Ettcheto M, Manzine PR, Castro-Torres RD, Verdaguer E, Olloquequi J, Vazquez M, Auladell C, Folch J and Camins A.

    Role of brain c-Jun N-terminal kinase 2 in the control of the insulin receptor and its relationship with cognitive performance in a high-fat diet pre-clinical model

    JOURNAL OF NEUROCHEMISTRY . 149(2): 255-268. Nº de citas: 6

    [doi:10.1111/jnc.14682]

  • Ettcheto M, Sánchez-López E, Gómez-Mínguez Y, Cabrera H, Busquets O, Beas-Zarate C, García ML, Carro E, Casadesus G, Auladell C, Vazquez M, Folch J and Camins A.

    Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.

    MOLECULAR NEUROBIOLOGY . 55(9): 7327-7339. Nº de citas: 22

    [doi:10.1007/s12035-018-0868-4]

  • Manzanares-Quintela A, Restrepo-Perdomo CA, Botteri G, Castillo H, Pascual-Pastó G, Cano F, Garcia-Alvarez L, Monterrubio C, Ruiz B, Vazquez M, Suñol M, Mora J, Tornero JA, Sosnik A and Carcaboso AM.

    Tissue Compatibility of SN-38-Loaded Anticancer Nanofiber Matrices

    ADVANCED HEALTHCARE MATERIALS . 7(15): . Nº de citas: 4

    [doi:10.1002/adhm.201800255]

  • Botteri G, Salvadó L, Gumà A, Lee Hamilton D, Meakin PJ, Montagut G, Ashford MLJ, Ceperuelo-Mallafré V, Fernández-Veledo S, Vendrell J, Calderón-Dominguez M, Serra D, Herrero L, Pizarro J, Barroso E, Palomer FX and Vazquez M.

    The BACE1 product sAPPß induces ER stress and inflammation and impairs insulin signaling.

    METABOLISM-CLINICAL AND EXPERIMENTAL . 85: 59-75. Nº de citas: 24

    [doi:10.1016/j.metabol.2018.03.005]

  • Montori M, Pedreira-Casahuga R, Boyer-Díaz Z, Lassot I, García-Martínez C, Orozco A, Cebrià-Romero J, Osorio-Conles O, Chacón MR, Vendrell J, Vazquez M, Desagher S, Jimenez-Chillaron JC and Gómez-Foix AM.

    GNIP1 E3 ubiquitin ligase is a novel player in regulating glycogen metabolism in skeletal muscle.

    METABOLISM-CLINICAL AND EXPERIMENTAL . 83: 177-187. Nº de citas: 37

    [doi:10.1016/j.metabol.2018.02.005]

  • Palomer FX, Pizarro J and Vazquez M.

    Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?

    TRENDS IN PHARMACOLOGICAL SCIENCES . 39(5): 452-467. Nº de citas: 51

    [doi:10.1016/j.tips.2018.02.010]

  • Palomer FX, Barroso E, Pizarro J, Peña L, Botteri G, Zarei M, Aguilar D, Montori M and Vazquez M.

    PPARß/d: A Key Therapeutic Target in Metabolic Disorders.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 19(3): . Nº de citas: 58

    [doi:10.3390/ijms19030913]

  • Palomer FX, Pizarro J, Barroso E and Vazquez M.

    Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 29(3): 178-190. Nº de citas: 326

    [doi:10.1016/j.tem.2017.11.009]